We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+28.1%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$544M
AUM Growth
+$63.9M
Cap. Flow
-$11.1M
Cap. Flow %
-2.03%
Top 10 Hldgs %
61.81%
Holding
70
New
10
Increased
18
Reduced
20
Closed
9

Top Buys

Rank Stock Value
1
OPEN icon
Opendoor
OPEN
+$18.9M
2
CBRS
Cerebras Systems
CBRS
+$14.2M
3
SPCX
SpaceX
SPCX
+$6.8M
4
AMZN icon
Amazon
AMZN
+$3.77M
5
TSLA icon
Tesla
TSLA
+$2.39M

Top Sells

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$13.8M
2
SE icon
Sea Limited
SE
+$11.4M
3
ARWR icon
Arrowhead Research
ARWR
+$9.8M
4
ESPR
Esperion Therapeutics
ESPR
+$9.04M
5
SPOT icon
Spotify
SPOT
+$5.72M

Sector Composition

Rank Sector Weight
1 Healthcare 32.64%
2 Technology 26.47%
3 Consumer Discretionary 23.86%
4 Financials 6.2%
5 Communication Services 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
26
Krystal Biotech
KRYS
$10.4B
$4.15M 0.76%
11,170
– –
ALNY icon
27
Alnylam Pharmaceuticals
ALNY
$31.7B
$3.42M 0.63%
11,372
-850
-7% -$256K
VRDN icon
28
Viridian Therapeutics
VRDN
$2.61B
$3.19M 0.59%
173,516
– –
BNTX icon
29
BioNTech
BNTX
$25.6B
$2.8M 0.51%
30,100
+3,100
+11% +$292K
HIMS icon
30
Hims & Hers Health
HIMS
$6.73B
$2.77M 0.51%
80,000
+40,000
+100% +$1.07M
MGTX icon
31
MeiraGTx Holdings
MGTX
$1.33B
$2.65M 0.49%
196,112
-16,000
-8% -$159K
ABEV icon
32
Ambev
ABEV
$44.1B
$2.52M 0.46%
802,167
-146,391
-15% -$458K
SRPT icon
33
Sarepta Therapeutics
SRPT
$2.2B
$2.45M 0.45%
136,500
+90,500
+197% +$1.71M
CRSP icon
34
CRISPR Therapeutics
CRSP
$5.58B
$2.45M 0.45%
44,974
+2,100
+5% +$111K
BEAM icon
35
Beam Therapeutics
BEAM
$3.03B
$2.41M 0.44%
70,282
+6,300
+10% +$190K
ZLAB icon
36
Zai Lab
ZLAB
$2.93B
$2.32M 0.43%
122,189
-10,000
-8% -$198K
MRNA icon
37
Moderna
MRNA
$55.1B
$2.1M 0.39%
29,994
– –
RNAC icon
38
Cartesian Therapeutics
RNAC
$290M
$1.58M 0.29%
151,675
-27,439
-15% -$203K
MICC
39
The Magnum Ice Cream Company N.V.
MICC
$12.3B
$1.5M 0.28%
+98,221
New +$1.53M
WVE icon
40
Wave Life Sciences
WVE
$993M
$1.4M 0.26%
241,010
– –
TSHA icon
41
Taysha Gene Therapies
TSHA
$1.88B
$1.35M 0.25%
198,900
+17,000
+9% +$101K
ZTS icon
42
Zoetis
ZTS
$32B
$1.24M 0.23%
+17,322
New +$1.63M
FDMT icon
43
4D Molecular Therapeutics
FDMT
$810M
$1.2M 0.22%
90,110
-80,146
-47% -$781K
FATE icon
44
Fate Therapeutics
FATE
$291M
$1.12M 0.21%
414,311
– –
LEGN icon
45
Legend Biotech
LEGN
$3.87B
$1.02M 0.19%
+35,400
New +$955K
RCKT icon
46
Rocket Pharmaceuticals
RCKT
$424M
$835K 0.15%
244,146
+2,000
+0.8% +$6.65K
NOV icon
47
NOV
NOV
$7.48B
$780K 0.14%
42,026
– –
BTG icon
48
B2Gold
BTG
$7.48B
$730K 0.13%
195,083
+98,606
+102% +$452K
TTE icon
49
TotalEnergies
TTE
$191B
$729K 0.13%
+10,723
New +$948K
LXEO icon
50
Lexeo Therapeutics
LXEO
$399M
$722K 0.13%
155,000
-50,000
-24% -$270K
1
2
3

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, Privium Fund Management held 70 positions worth $544M, up 13% from $480M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Privium Fund Management's Q2 2026 filing shows 10 new, 18 increased, 20 reduced and 9 closed positions. Its largest new stake was Opendoor: 3,940,904 shares worth $18.2M. The largest sale was Coinbase, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Privium Fund Management's largest Q2 2026 buy was Opendoor: 3,940,904 shares worth $18.2M.
  • Privium Fund Management added most to Amazon in Q2 2026, an estimated $3.77M increase.
  • Privium Fund Management's biggest Q2 2026 reduction was Arrowhead Research, cutting an estimated $9.8M.
  • Privium Fund Management fully exited Coinbase in Q2 2026, selling an estimated $13.8M.
  • Privium Fund Management's ten largest holdings make up 62% of its $544M portfolio in Q2 2026.
  • Privium Fund Management opened 10 new positions and closed 9 in Q2 2026.
  • Privium Fund Management's portfolio value rose 13% quarter-over-quarter to $544M.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.